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RADIOMIMETIC DRUG – “BLEOMYCIN-” INDUCED DNA DAMAGE REPAIR BY ALSTONIA 
SCHOLARIS BARK EXTRACTS – A G2 ASSAY-BASED EVIDENCE
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Objective: The present study initiated to know the probable DNA damage repair by Alstonia scholaris extracts using bleomycin-induced chemosensitive 
G2 assay in in vitro cultured human blood lymphocytes.
Results: The results indicated that aqueous as well as methanolic bark extracts had enough potential to repair DNA damage caused by bleomycin. The 
extracts (both aqueous and methanolic) from stem or leaves were not promising.
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INTRODUCTION
Alstonia scholaris Linn. (Family: Apocynaceae) is commonly known as 
the “Saptaparni” or “Devil’s tree” in India. It is widely distributed in 
drier forests, Western Himalayas, Western Ghats, and Southern region 
of India. It is a well-known remedy for the treatment of various types 
of disorders in the Ayurvedic, Homoeopathic, and Folklore system of 
medicine [1,2].
Alkaloids are one of the major constituents of Alstonia species [3-12]. 
Over 70 different types of alkaloids have been reported in different parts 
of A. scholaris such as root, stem bark, leaves, fruit, and flower [13]. 
Among other constituents, isookanin-7-o-alpha-lrhamnopyranoside, 
flavanone glycoside [14] and alstonoside, and secoiridoid glucoside [15] 
have been recorded. Iridoids, coumarins, flavonoids, leucoanthocyanins, 
reducing sugars, simple phenolics, steroids, saponins, and tannins were 
also found in the A. scholaris [16]. Presence of agr-amyrin, bgr-amyrin, 
lupeol acetate, venenative, rhazine, and yohimbine has been noted  [17]. 
Linalool, cis- and trans-linalool oxides (furanoid and pyranoid), alpha-
terpineol, 2-phenylethyl acetate and terpinen-4-ol [18], and steroids [19] 
have also been reported as phytoconstituents of the Alstonia sp.
In India, the therapeutic use of A. scholaris has been described in 
both codified and non-codified drug systems for the treatment 
of malaria, jaundice, gastrointestinal troubles, and cancer and in 
many other ailments [13]. Other species, Alstonia macrophylla has 
been used in conventional medicines in Thailand, Malaysia, and 
Philippines as a general tonic, aphrodisiac, anticholeric, antidysentery, 
antipyretic, emmenagogue, and vulnerary agents [1,20-24]. At times, 
A. macrophylla is also used as a substitute for A. scholaris in various 
herbal pharmaceutical preparations.
Several biological and pharmacological studies were undertaken 
to evaluate traditional and ethnopharmacological claims of 
A. scholaris. Thus, so far, various biological and pharmacological 
activities such as antimalarial [25,26] antimicrobial [27-30], 
antidiarrheal [31], antioxidant [32-35], antidiabetic [36], anticancer 
and cytotoxicity [37-39], analgesic [40], anti-inflammatory [41], 
hepatoprotective and central nervous system [42-43], wound 
healing [44], immunostimulating [45,46], antitussive and 
antiasthmatic [47], and antifertility [17] properties have been 
reported to A. scholaris.
Gupta et al. [48] reported radioprotective efficacy of bark extracts of 
A. scholaris in mice against radiation-induced hematological (total 
number of erythrocytes, percentage of hematocrit, and hemoglobin) 
and biochemical alterations (lipid peroxidation and glutathione 
content). The bark extract of A. scholaris was found to restore the 
total leukocytes and differential leukocytes (lymphocytes, monocytes, 
neutrophils, and non-neutrophilic granulocytes) count in A. scholaris 
bark extract pre-treated animals as compared to the irradiated control 
group. Another study [49] from the same laboratory reported that 
radiation-induced augmentation in lipid peroxidation and cholesterol 
level was significantly ameliorated in mice fed with A. scholaris bark 
extract. Jahan and Goyal [50] demonstrated that A. scholaris bark 
extract pre-treatment in mice provides protection against radiation-
induced cytogenetic damage in the form of chromosomal aberrations 
and micronuclei induction in bone marrow cells.
From the foregoing discussion, we hypothesized the applicability 
of A. scholaris (L.) R. Br. as a plant with protective property against 
chemical-induced cytogenetic damage. The present study was, 
therefore, initiated to know the probable DNA damage repair by 
A. scholaris extracts using bleomycin-induced chemosensitive G2 assay 
in in vitro cultured human blood lymphocytes.
METHODS
The bark, stem, and leaves of A. scholaris were collected separately 
and dried for 2–3 days at room temperature. After drying, they were 
ground crumbly. The finely ground powder was placed in a porous bag 
(thimble) made of strong filter paper. The thimble was placed in the 
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chamber of the Soxhlet apparatus. Two separate solvents (methanol 
and double-distilled water) were used for extraction. The extraction 
assembly was set up as described [51]. Hot continuous extraction was 
carried out. After 5–6 refluxing cycles, a drop of solvent from the siphon 
tube was collected and observed for residue mark after evaporation. 
When no residue was found from the evaporated drop so collected, 
the refluxing cycle was terminated. The solvent containing extract 
siphoned out into the distillation still was collected and allowed to cool. 
The liquid content was evaporated and condensed. This was stored 
in sterile labeled container at 4°–8°C until further use. Extracts were 
redissolved in sterile pyrogen-free water and sterilized using syringe 
filters before use.
G2 assay
The experiments were carried out with blood samples collected from 12 
healthy volunteers. A total of 28 culture vials from each individual were 
set up for lymphocyte cultures [52]. These culture tubes (vials) were 
divided into two groups of fourteen each. The first group was labeled 
as “G0,” while the second as “G2.” In both groups, initial vials (“A”) were 
kept untreated so as to act as a control, the second vial labeled (“B”) 
received treatment of alone dose of BLM (15 μg/ml), while vials labeled 
“C” to “N” were treated as shown in Table 1. At the 71st h, the cells were 
treated with 100 μl of 0.001% colchicine. The cultures were terminated 
at the 72th h of incubation. Routine air-dried preparations were made. 
Each slide was blind coded, conveniently stained in 2% Giemsa, and 
scored under ×100 oil immersion lens. To avoid observer’s bias, all 
slides were scored twice by different observers. The average of total 
chromatid aberrations recorded by each observer has been tabulated.
RESULTS AND DISCUSSION
The results of G2 assay revealed a statistically significant (p<0.05) 
reduction in the total chromatid breaks from control cultures [52] 
belonging to “G2” group as compared to control cultures (71) belonging 
to “G0” group (Table 2), indicating that DNA repair mechanisms were 
functional in all blood donors studied.
The total chromatid breaks were significantly less in cultures belonging 
to “G2” group as compared to respective cultures belonging to “G0” 
group for all groups studied. However, there was variation in the 
level of significance with each treatment condition. The highest level 
(p<0.0001) of reduction in total chromatid breaks was observed from 
those cultures treated with aqueous bark extracts at G2 phase (22) than 
those at G0 phase (60). No significant reduction was observed when G2 
tubes treated with stem and leaf extracts were compared to respective 
tubes of G0 group.
Even though many substances with assumed cytoprotective effects are 
the subjects of laboratory and/or clinical studies, at the moment, there 
is no ideal protective strategy to be universally employed in patients 
receiving radio- or chemotherapy [54]. It has been established during 
the last two decades that products derived from natural sources could 
be used as non-toxic radioprotectants.
Majority of the plants are either radioprotectors or radiomodulators, 
but plants with potency to repair the damage caused by radiation, 
Table 1: Treatment protocol for G2 assay
Group Vials Treatment at 0 h Treatment at 70 h
G0 A Control Nil
B Bleomycin (15 µg/ml)
C Aqueous bark extract (50 µg/ml)
D Methanolic bark extract (50 µg/ml)
E Aqueous stem extract (50 µg/ml) 
F Methanolic stem extract (50 µg/ml) 
G Aqueous leaf extract (50 µg/ml)
H Methanolic leaf extract (50 µg/ml) 
I Aqueous bark extract (50 µg/ml) + Bleomycin (15 µg/ml)
J Methanolic bark extract (50 µg/ml) + Bleomycin (15 µg/ml)
K Aqueous stem extract (50 µg/ml) + Bleomycin (15 µg/ml)
L Methanolic stem extract (50 µg/ml) + Bleomycin (15 µg/ml)
M Aqueous leaf extract (50 µg/ml) + Bleomycin (15 µg/ml)
N Methanolic leaf extract (50 µg/ml) + Bleomycin (15 µg/ml)
G2 A Control Bleomycin (5 µg/ml)
B Bleomycin (15 µg/ml)
C Aqueous bark extract (50 µg/ml)
D Methanolic bark extract (50 µg/ml)
E Aqueous stem extract (50 µg/ml) 
F Methanolic stem extract (50 µg/ml) 
G Aqueous leaf extract (50 µg/ml)
H Methanolic leaf extract (50 µg/ml) 
I Aqueous bark extract (50 µg/ml) + Bleomycin (15 µg/ml)
J Methanolic bark extract (50 µg/ml) + Bleomycin (15 µg/ml)
K Aqueous stem extract (50 µg/ml) + Bleomycin (15 µg/ml)
L Methanolic stem extract (50 µg/ml) + Bleomycin (15 µg/ml)
M Aqueous leaf extract (50 µg/ml) + Bleomycin (15 µg/ml)
N Methanolic leaf extract (50 µg/ml) + Bleomycin (15 µg/ml)
Devastating  effects  of  radiation  pose  the  need  for 
radioprotectors to safeguard different organs of our body and to
 avoid the lethality associated with these radiations. Radioprotector 
is  a  group  of  measures,  designed  to  ensure  man  and  his 
environment are protected against  the harmful  effect  of  ionizing 
radiations. They are effective to save our bodies from wanted or 
unwanted radiations. Hazardous radiations cause consequential 
injuries  to  biological  systems;  therefore,  it  is  a  necessity  to 
formulate  such  pharmacologically  dynamic  radioprotector  that  can 
render  protection  to  humans  against  destructive  and  damaging 
outcome of ionizing radiation. Cellular adaptations and mechanisms to 
counteract  the  lethal  consequences  of  damage  by  radiation  have 
been  well  studied  [53].  Radioprotectors  ensure  the  elevation  of 
non-protein  sulfhydryl  groups,  reduction  in  lipid  peroxidation,  and 
upregulation  of  free  radical  scavenging  activity  through 
transcription upregulation of antioxidant enzymes such as glutathione 
transferase,  catalase,  superoxide  dismutase,  and  glutathione 
peroxidase. Radiation caused damage can also be neutralized by 
the upregulation of DNA repair activity. Other mechanisms, which 
help in radioprotection, are the inactivation of protein kinase (PK)-C, nitric 
oxide,  mitogen-activated  PK,  and  downregulation  of  several  other 
effectors responsible for molecular damage.
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i.e., radio-mitigators have been rarely reported. It is very likely that 
no single mechanism can account for the protection offered by a 
radioprotective drug [55]. Radiation is known to produce oxygen-free 
radicals which are implicated in the process of DNA damage, cell killing, 
mutagenesis, and carcinogenesis [56]; hence, it is reasonable to assume 
that agents capable of scavenging free radicals would play a significant 
role in modulating these processes. The radioprotection of normal cells 
by a number of synthetic and natural compounds has been reported to 
be mediated through free radical scavenging activity [56].
Different radioprotectants offer protection to cellular molecules by 
different mechanisms [57]. Some of these compounds protect the 
target molecules due to their antioxidant potentials by neutralizing the 
free radicals, others enhance the cellular DNA repair, certain modifies 
the signaling pathways, some modulate the immune system, and few 
contribute to a combination of above-mentioned mechanisms [58,59].
The bark of A. scholaris is the most intensively used part of the plant and 
is used in many compound herbal formulas [60]. In the present study, 
the qualitative and quantitative analysis of extracts from the bark of 
A. scholaris revealed the presence of flavonoids. In addition, the quantity 
of terpenoids was highest in aqueous extracts as compared to other 
compounds followed by steroids, alkaloids, and phenolic compounds.
It has been reported that plant secondary metabolites such as 
flavonoids and terpenoids play an important role in defense against 
free radicals [58]. The free radical scavenging and antioxidant potential 
of A. scholaris observed in the present finding could be attributed to 
terpenoids, steroids, alkaloids, flavonoids, and phenolic compounds. 
Thus, antioxidant and free radical scavenging potential of the plant so 
exhibited could be responsible for radioprotective potentials. Plants 
that produce antioxidants which scavenge free radicals caused by 
radiation exhibit radioprotective action.
So far, the explanation for radioprotective or radiomodulatory action 
of A. scholaris has been attributed to its antioxidant potentials and free 
radical scavenging activity [48,50,61-65]. The key aspects of radiation 
protective agents are the practical need to use them in specific scenarios 
of radiation exposure and the corresponding tactical and technical 
requirements for medical preparations [60]. Radioprotectors realize 
radiation protective action at the cellular level in the course of rapidly 
proceeding radiation-chemical reactions. At the same time, when the 
ionizing radiation energy is absorbed, these agents partially neutralize 
the “oxygen effect” as a radiobiological phenomenon, especially in the 
radiolysis of DNA [66].
Certain group of agents used in medicine exerts their effect on system 
levels by promoting the acceleration of the post-radiation restoration 
of radiosensitive tissues and is not directly connected with the primary 
radiation chemical and biochemical processes in cells that occur during 
the absorption of the energy from ionizing radiation. For this reason, 
these agents are effective not only at administration before irradiation 
but also during the early period after, acting as mitigators [60]. 
Radiomitigators exert their effect on system levels by promoting 
the acceleration of the post-radiation restoration of radiosensitive 
tissues through an activation of pro-inflammatory signaling pathways 
and a stimulation of hematopoietic stem and progenitor cells and 
mesenchymal stromal cell mobilization [60].
DNA repair is a ubiquitous mechanism that is critical to maintain 
the integrity of the genome [60]. Few plants (Mentha piperita and 
Mentha arvensis [68,69], Grewia asiatica [70,71], and Arabidopsis [72]) 
have enhanced radiation-induced DNA damage repair processes. Our 
finding adds to this body of information one more plant (A. scholaris) 
with such mitigatory action. To the best of our knowledge, this study 
is the first of its kind, where radiomitigatory activity of the said plant 
has been reported using cultured human lymphocytes. These data have 
important application for the protection of human lymphocytes from 
the genetic damage and side effects induced by X-ray irradiation in 
patients undergoing radiotherapy. However, an extended examination 
of actual and individual phytochemicals from the plant responsible 
for radioprotection, radiomodulation, and radiomitigation would 
help better understand the probable mechanisms and increase the 
applicability value of the plant.
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